ESC Professional Premium Access

Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease

Congress Presentation

About the speaker

Doctor Mattia Galli

Sapienza University of Rome, Rome (Italy)
0 follower

5 more presentations in this session

HDAC inhibitor CS014 inhibits platelet activity, small and large vessel thrombosis while maintaining haemostasis in a dose-dependent manner

Speaker: Associate Professor M. Holinstat (Ann Arbor, US)


Superiority of CS585 as a selective prostacyclin receptor agonist in prevention of thrombosis

Speaker: Ms L. Stanger (Ann Arbor, US)


Variability of the antithrombotic effect of acetylsalicylic acid with the administration of different dosages: reality or myth?

Speaker: Doctor J. Lima Lopes (Amadora, PT)


Antiplatelet effect of acetylsalicylic acid in patients early after cardiac valve surgery: comparative investigation of the impairment of platelet inhibition by dipyrone versus acetaminophen

Speaker: Professor D. Trenk (Bad Krozingen, DE)


CYP2C19 genotype prevalence and association with recurrent myocardial infarction in British-South Asians treated with clopidogrel

Speaker: Doctor E. Magavern (London, GB)


Access the full session

Current and novel antiplatelet therapy in cardiovascular disease

Speakers: Doctor M. Galli, Associate Professor M. Holinstat, Ms L. Stanger, Doctor J. Lima Lopes, Professor D. Trenk...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb